Published in Pediatr Clin North Am on November 01, 1972
Modulation of human eosinophil polymorphonuclear leukocyte migration and function. Am J Pathol (1976) 0.93
The idiopathic hypereosinophilic syndrome. Arch Dis Child (1987) 0.91
Relevance of eosinophilia and hyper-IgE in immigrant children. Medicine (Baltimore) (2014) 0.79
The International Neuroblastoma Pathology Classification (the Shimada system). Cancer (1999) 6.42
Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. N Engl J Med (1998) 4.39
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol (1999) 3.35
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study. J Clin Oncol (1998) 1.88
Ferrokinetics in the syndrome of familial hypoferremic microcytic anemia with iron malabsorption. J Pediatr Hematol Oncol (1999) 1.84
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study. J Clin Oncol (2000) 1.74
International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer (2001) 1.58
Iron metabolism in copper-deficient swine. J Clin Invest (1968) 1.51
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study. J Clin Oncol (2000) 1.42
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. J Clin Oncol (2000) 1.40
Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group. J Clin Oncol (1998) 1.22
Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor. Blood (1986) 1.16
Regulation of human polymorphonuclear leukocyte superoxide release by cellular responses to chemotactic peptides. J Immunol (1981) 1.10
Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia. Cancer (1991) 1.07
Thyrotoxicosis associated with Aspergillus thyroiditis in chronic granulomatous disease. J Pediatr (1972) 1.05
Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis. J Natl Cancer Inst (1995) 1.02
Chemotactic factor enhancement of superoxide release from fluoride and phorbol myristate acetate stimulated neutrophils. Blood (1981) 1.01
The occurrence of leukemia in patients with the Shwachman syndrome. J Pediatr (1981) 1.00
Nasogastric tube feeding at home: a method for adjunctive nutritional support of malnourished patients. Am J Clin Nutr (1981) 0.98
Anemia of adjuvant-induced inflammation in rats. Proc Soc Exp Biol Med (1967) 0.97
Prognostic implications of blast cell morphology in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. Cancer Treat Rep (1985) 0.95
Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group. J Clin Oncol (1991) 0.94
Early response to induction therapy as a predictor of disease-free survival and late recurrence of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group. J Clin Oncol (1989) 0.92
Hypercalcemia associated with immunoreactive parathyroid hormone in a malignant rhabdoid tumor of the kidney (rhabdoid Wilms' tumor). Cancer (1984) 0.91
Regulation of neutrophil inflammatory mediator release: chemotactic peptide activation of stimulus-dependent cytotoxicity. J Immunol (1983) 0.91
Clinical features of myelokathexis and treatment with hematopoietic cytokines: a case report of two patients and review of the literature. J Pediatr Hematol Oncol (1997) 0.91
Landmark perspective: The legacy of well-water methemoglobinemia. JAMA (1987) 0.89
Control of erythropoiesis in rats with adjuvant-induced chronic inflammation. Blood (1973) 0.89
Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems. J Pediatr Surg (1995) 0.89
Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: histopathologic features-a report from the Children's Cancer Group. Med Pediatr Oncol (2001) 0.89
Ultrastructure of the lung in idiopthic pulmonary hemosiderosis. Am J Med (1972) 0.86
Iron deficiency and infection: fact or fable? Am J Dis Child (1975) 0.85
Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experience. Ann Surg Oncol (1995) 0.84
Intravenous lipid emulsions and human neutrophil function. J Pediatr (1981) 0.83
Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of children. Blood (1982) 0.83
Systemic metastases in primary intracranial germinoma. Case report and literature review. Cancer (1985) 0.82
Differential inhibition of neutrophil superoxide generation by nonsteroidal antiinflammatory drugs. Inflammation (1984) 0.81
Dissociation of erythroblastic and myeloblastic proliferation in erythroleukemia. Am J Dis Child (1972) 0.81
Investigations of the biological activity of leukotriene A4 in human polymorphonuclear leukocytes. Biochem Biophys Res Commun (1985) 0.81
Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma. Med Pediatr Oncol (2000) 0.80
Enhancement of chemotactic factor-stimulated neutrophil oxidative metabolism by leukotriene B4. Blood (1984) 0.80
Stimulation by lipoxygenase products of superoxide anion production in FMLP-treated neutrophils. Lipids (1985) 0.80
Long-term granulocyte-macrophage colony-stimulating factor and immunosuppression in the treatment of acquired severe aplastic anemia. J Pediatr Hematol Oncol (1995) 0.80
Stimulation of neutrophil oxidative metabolism by indomethacin. Agents Actions (1985) 0.79
EXcretion and distribution of iron during chronic deferoxamine therapy. Blood (1971) 0.79
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular. Cancer (2000) 0.79
Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumors. Med Pediatr Oncol (2000) 0.79
Acute idiopathic thrombocytopenic purpura--management in childhood. Blood (1997) 0.78
Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum. Am J Med (1988) 0.78
Telomerase expression in primary neuroblastomas. Eur J Cancer (1997) 0.77
Hodgkin's disease in three children from an Amish kindred. J Pediatr (1972) 0.77
High-dose cytosine arabinoside and etoposide: an effective regimen without anthracyclines for refractory childhood acute non-lymphocytic leukemia. Leukemia (1997) 0.76
Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. The use of nutritional therapy. Am J Pediatr Hematol Oncol (1984) 0.76
Vitamin K and the older infant. Am J Dis Child (1972) 0.75
Testicular infiltrate in childhood acute lymphocytic leukemia. The need for biopsy in suspected relapse. Urology (1980) 0.75
Neutrophil labeling with indium-111: tropolone vs. oxine. Radiology (1983) 0.75
Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation. Lipids (1985) 0.75
Erythroleukemia in an infant with neurofibromatosis. J Pediatr (1978) 0.75
Hemoglobin S, the pneumococcus, and the spleen. Am J Dis Child (1972) 0.75
Immunologic factors in human melanoma "metastatic" to products of gestation (with exchange transfusion of infant to mother). Surgery (1971) 0.75
Angiography of the hemophilic joint. Radiology (1979) 0.75
Neonatal haematological abnormalities associated with maternal disease. Clin Haematol (1978) 0.75
Juvenile features in adult-type chronic granulocytic leukemia. Am J Hematol (1984) 0.75
Recognition and management of blood disorders in children. Med Times (1979) 0.75
Sickle cell disease. Dis Mon (1981) 0.75
Nitrosourea-associated pulmonary fibrosis. Cancer Treat Rep (1980) 0.75
Multiple thromboemboli. Am J Dis Child (1978) 0.75
Childhood leukemia: meeting the needs of patient and family. Mo Med (1970) 0.75